RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND WAYS OF USE THEREOF Russian patent published in 2024 - IPC C07K14/705 C07K16/28 C12N5/783 A61K35/17 A61P35/00 

Abstract RU 2816370 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to an isolated polynucleotide encoding a polypeptide containing a chimeric antigen receptor for CD19 (CAR), in which the polypeptide does not contain a rituximab binding site, and wherein the polynucleotide comprises a short EF1a promoter which is capable of expressing a chimeric antigen receptor for CD19 (CAR) in a mammalian T cell, as well as to a vector and a T-cell containing it. Also disclosed is a pharmaceutical composition containing said cell.

EFFECT: invention is effective for treating a disease or disorder associated with high CD19 levels in a subject.

25 cl, 13 dwg, 5 tbl, 4 ex

Similar patents RU2816370C2

Title Year Author Number
ANTIBODIES TO CHIMERIC ANTIGEN RECEPTORS DERIVED FROM 4G7 2020
  • Pertel, Tomas Charlz
  • Sasu, Barbra Dzhonson
  • Saj, Tao
RU2826051C2
METHODS AND COMPOSITIONS FOR ENHANCING MULTIPLICATION AND CYTOTOXICITY OF NATURAL KILLER CELLS 2020
  • Trager, Dzhejms, Barnabi
  • Lazetik, Aleksandra, Lejda, Liana
  • Chan, Ivan
  • Vokhra, Anmol
RU2839702C2
TYPES OF COMBINATION THERAPY USING CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS 2017
  • Anak, Ozlem
  • Bajlik, Sejnela
  • Brogdon, Dzhennifer
  • Kemeron, Dzhon, Skott
  • Chou, Uillyam
  • Khauard, Denni, Roland, Ml.
  • Isaaks, Randi
  • Dzhun, Karl, Kh.
  • Lejsi, Sajmon
  • Mod, Shennon
  • Milenkhorst, Yan, Dzh.
  • Shaster, Stiven
  • Kintas-Kardama, Alfonso
  • Grapp, Stefan
  • Bitter, Khans
RU2809160C2
CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS 2015
  • Brogdon, Jennifer
  • Gill, Saar
  • Glass, David
  • Kenderian, Saad
  • Loew, Andreas
  • Mannick, Joan
  • Milone, Michael
  • Murphy, Leon
  • Porter, David, L.
  • Ruella, Marco
  • Wang, Yongqiang
  • Wu, Qilong
  • Zhang, Jiquan
RU2724999C2
CHIMERIC ANTIGEN RECEPTORS AND WAYS OF USE THEREOF 2020
  • Ejbyudzhoub, Aida
  • Blankenship, Dzhon
  • Bondantsa, Attilio
  • Brogdon, Dzhennifer
  • Bu, Desyu
  • De Vita, Serena
  • Dranoff, Glenn
  • Engels, Boris
  • Fleming, Toni
  • Grin, Majkl, R.
  • Khong, Konni
  • Chzhu, Syuj
  • Gimares, Karla, Patrisiya
  • Lem, Dzhoni, Ueji
  • Granda, Brajan, Valter
  • Chzhan, Chunkhoj
  • Trinor, Luiz
  • Stejn, Endryu, Mark
  • Sokhoni, Akash
  • Kodrasi, Olya
  • Prajs, Endryu
  • Lim, Khiungvook
  • Prejtiko, Elizabet, Doroti
  • Khuan, Lu
  • Kholmberg, Brajan
  • Khek, Ennisha
RU2841244C2
METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR 2015
  • Bedoya Felipe
  • Ghassemi Saba
  • June Carl H.
  • Levine Bruce L.
  • Melenhorst Jan J.
  • Milone Michael C.
  • Powell Daniel J. Jr.
  • Zheng Zoe
RU2751362C2
CELL 2015
  • Pyule Marten
  • Kordoba Shon
  • Onuokha Simobi
  • Tomas Sajmon
RU2768019C2
CD20 THERAPY, CD22 THERAPY AND COMBINATION THERAPY WITH CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR (CAR) K CD19 2016
  • Bitter, Hans
  • Bordeaux,Jennifer, Mary
  • Brannetti, Barbara
  • Brogdon, Jennifer
  • Dakappagari, Naveen, Kumar
  • Gill, Saar
  • Highfill, Steven
  • Huang, Lu
  • June, Carl, H.
  • Kim, Ju, Young
  • Lei, Ming
  • Li, Na
  • Loew, Andreas
  • Orlando, Elena
  • Ruella, Marco
  • Tran, Thai
  • Zhahg, Jimin
  • Zhou, Li
RU2752918C2
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY 2013
  • Kloss, Christopher C.
  • Sadelain, Michel
RU2832516C2
NEW CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS CONTAINING TNFR2 DOMAINS 2019
  • Abel, Tobias
  • Fenard, David
  • Gertner-Dardenne, Julie
  • Meyer, Francois
RU2808254C2

RU 2 816 370 C2

Authors

Pertel, Tomas Charlz

Sasu, Barbra Dzhonson

Leonard, Mark U.

Dates

2024-03-28Published

2020-04-24Filed